Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic and local intestinal pharmacokinetics of irinotecan
NL-OMON56972Recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of irinotecan in colorectal cancer (CRC) and pancreatic cancer (PC), sponsored by Catharina Ziekenhuis. Primary endpoint: Pharmacokinetics of irinotecan, SN-38, and SN-38G in plasma and intestines. Started Sep 2025; status: recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON56972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56972.